South-Korea based Philosys has received 510K approval from the US Food and Drug Administration (FDA) for its Gmate SMART Blood Glucose Monitoring System.
Philosys noted that Gmate SMART meter is the size of a quarter and connects to the headphone jack on the iPhone, iPod touch or iPad, while using the free Gmate SMART app to deliver blood glucose test results, without the use of an adapter or Bluetooth device.
The operating system of the iOS device has been used by the patent pending technology.
The Gmate SMART app and meter incorporates diabetes management directly to an iOS device, and offers the features such as goal setting, graphing, and the ability to email or text blood glucose test results directly to healthcare provider.
Chronic diseases such as diabetes are costly and taxing on the current system, according to Center for Technology Innovation at Brookings.
Philosys sales senior vice-president Mike Tickle said the company continues its efforts to be a technology leader for the diabetes mobile monitoring arena.
"The Gmate SMART will give our customers TeleHealth capabilities with the accuracy and quality they deserve at a cost effective price," Tickle added.
Philosys manufactures medical, diagnostics and analytical instruments.